We offer analysis of competition issues in the pharmaceuticals and healthcare sector, building our analysis on our understanding of the way in which price controls, doctors' budgets and other regulatory or institutional arrangements may affect competition.
We can assess the nature and effectiveness of competition in different parts of the supply chain, distinguishing logistical aspects from healthcare decisions.
We have empirical experience of using large industry-standard datasets in conjunction with qualitative studies as the basis for economic analyses.
Our consultants have worked for healthcare companies and for public authorities in several jurisdictions.
We maintain a rolling review of healthcare news and developments relevant to our work.